Cargando…
Resistance Exercise Dosage in Men with Prostate Cancer: Systematic Review, Meta-analysis, and Meta-regression
PURPOSE: Resistance exercise improves an array of treatment-related adverse effects in men with prostate cancer; however, the minimal dosage required is unknown. We systematically reviewed the resistance training effects in prostate cancer patients to determine the minimal dosage regarding the exerc...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7886340/ https://www.ncbi.nlm.nih.gov/pubmed/32890199 http://dx.doi.org/10.1249/MSS.0000000000002503 |
_version_ | 1783651776685146112 |
---|---|
author | LOPEZ, PEDRO TAAFFE, DENNIS R. NEWTON, ROBERT U. GALVÃO, DANIEL A. |
author_facet | LOPEZ, PEDRO TAAFFE, DENNIS R. NEWTON, ROBERT U. GALVÃO, DANIEL A. |
author_sort | LOPEZ, PEDRO |
collection | PubMed |
description | PURPOSE: Resistance exercise improves an array of treatment-related adverse effects in men with prostate cancer; however, the minimal dosage required is unknown. We systematically reviewed the resistance training effects in prostate cancer patients to determine the minimal dosage regarding the exercise components (type, duration, volume, and intensity) on body composition, physical function, muscle strength, cardiorespiratory fitness, body mass index, and prostate-specific antigen. METHODS: Using PRISMA guidelines, MEDLINE, CINAHL, EMBASE, SPORTDiscus, and Web of Science databases were searched. Eligible randomized controlled trials examined prostate cancer patients undertaking resistance-based exercise programs during or after treatment. Meta-analysis was undertaken when more than three studies were included. Associations between mean differences and exercise components were tested by univariate and multivariate meta-regression analysis. RESULTS: Twenty-three articles describing 21 trials and involving 1748 prostate cancer patients were included. Exercise improved fat mass (−1% in body fat and −0.6 kg in fat mass), lean mass (~0.5 kg in lean and appendicular lean mass), functional capacity (i.e., chair rise, 400-m test, 6-m fast walk, and stair climb tests), and fitness outcomes (i.e., V̇O(2peak) and muscle strength) (P = 0.040–<0.001) with no change in body mass index or prostate-specific antigen (P = 0.440–0.735). Meta-regression indicated no association between exercise type, resistance training duration, weekly volume and intensity, and primary outcomes (P = 0.075–0.965). There was a significant association between exercise intensity and chest press muscle strength (favoring moderate intensity, P = 0.012), but not in other secondary outcomes. CONCLUSION: In untrained older men with prostate cancer initiating an exercise program, lower volume at moderate to high intensity is as effective as higher volume resistance training for enhancing body composition, functional capacity, and muscle strength in the short term. A low exercise dosage may help reduce barriers to exercise and enhance adherence. |
format | Online Article Text |
id | pubmed-7886340 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-78863402021-02-22 Resistance Exercise Dosage in Men with Prostate Cancer: Systematic Review, Meta-analysis, and Meta-regression LOPEZ, PEDRO TAAFFE, DENNIS R. NEWTON, ROBERT U. GALVÃO, DANIEL A. Med Sci Sports Exerc Clinical Sciences PURPOSE: Resistance exercise improves an array of treatment-related adverse effects in men with prostate cancer; however, the minimal dosage required is unknown. We systematically reviewed the resistance training effects in prostate cancer patients to determine the minimal dosage regarding the exercise components (type, duration, volume, and intensity) on body composition, physical function, muscle strength, cardiorespiratory fitness, body mass index, and prostate-specific antigen. METHODS: Using PRISMA guidelines, MEDLINE, CINAHL, EMBASE, SPORTDiscus, and Web of Science databases were searched. Eligible randomized controlled trials examined prostate cancer patients undertaking resistance-based exercise programs during or after treatment. Meta-analysis was undertaken when more than three studies were included. Associations between mean differences and exercise components were tested by univariate and multivariate meta-regression analysis. RESULTS: Twenty-three articles describing 21 trials and involving 1748 prostate cancer patients were included. Exercise improved fat mass (−1% in body fat and −0.6 kg in fat mass), lean mass (~0.5 kg in lean and appendicular lean mass), functional capacity (i.e., chair rise, 400-m test, 6-m fast walk, and stair climb tests), and fitness outcomes (i.e., V̇O(2peak) and muscle strength) (P = 0.040–<0.001) with no change in body mass index or prostate-specific antigen (P = 0.440–0.735). Meta-regression indicated no association between exercise type, resistance training duration, weekly volume and intensity, and primary outcomes (P = 0.075–0.965). There was a significant association between exercise intensity and chest press muscle strength (favoring moderate intensity, P = 0.012), but not in other secondary outcomes. CONCLUSION: In untrained older men with prostate cancer initiating an exercise program, lower volume at moderate to high intensity is as effective as higher volume resistance training for enhancing body composition, functional capacity, and muscle strength in the short term. A low exercise dosage may help reduce barriers to exercise and enhance adherence. Lippincott Williams & Wilkins 2021-03 2020-09-04 /pmc/articles/PMC7886340/ /pubmed/32890199 http://dx.doi.org/10.1249/MSS.0000000000002503 Text en Copyright © 2020 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American College of Sports Medicine. This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND) (http://creativecommons.org/licenses/by-nc-nd/4.0/) , where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. |
spellingShingle | Clinical Sciences LOPEZ, PEDRO TAAFFE, DENNIS R. NEWTON, ROBERT U. GALVÃO, DANIEL A. Resistance Exercise Dosage in Men with Prostate Cancer: Systematic Review, Meta-analysis, and Meta-regression |
title | Resistance Exercise Dosage in Men with Prostate Cancer: Systematic Review, Meta-analysis, and Meta-regression |
title_full | Resistance Exercise Dosage in Men with Prostate Cancer: Systematic Review, Meta-analysis, and Meta-regression |
title_fullStr | Resistance Exercise Dosage in Men with Prostate Cancer: Systematic Review, Meta-analysis, and Meta-regression |
title_full_unstemmed | Resistance Exercise Dosage in Men with Prostate Cancer: Systematic Review, Meta-analysis, and Meta-regression |
title_short | Resistance Exercise Dosage in Men with Prostate Cancer: Systematic Review, Meta-analysis, and Meta-regression |
title_sort | resistance exercise dosage in men with prostate cancer: systematic review, meta-analysis, and meta-regression |
topic | Clinical Sciences |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7886340/ https://www.ncbi.nlm.nih.gov/pubmed/32890199 http://dx.doi.org/10.1249/MSS.0000000000002503 |
work_keys_str_mv | AT lopezpedro resistanceexercisedosageinmenwithprostatecancersystematicreviewmetaanalysisandmetaregression AT taaffedennisr resistanceexercisedosageinmenwithprostatecancersystematicreviewmetaanalysisandmetaregression AT newtonrobertu resistanceexercisedosageinmenwithprostatecancersystematicreviewmetaanalysisandmetaregression AT galvaodaniela resistanceexercisedosageinmenwithprostatecancersystematicreviewmetaanalysisandmetaregression |